Serotonin transporter gene associated with lithium prophylaxis in mood disorders

Pharmacogenomics Journal

Volumn 1, Issue 1, 2001, Pages 71-77

  Serretti, A ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Bipolar disorder; Follow up studies; Lithium; Pharmacogeneties

Indexed keywords

CARRIER PROTEIN; LITHIUM; MEMBRANE PROTEIN; NERVE PROTEIN; SEROTONIN TRANSPORTER; SLC6A4 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; MOOD DISORDER; PROSPECTIVE STUDY;

ADULT; AGED; CARRIER PROTEINS; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; LITHIUM; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MOOD DISORDERS; NERVE TISSUE PROTEINS; PROSPECTIVE STUDIES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 0035757578     PISSN: 1470269X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500006     Document Type: Article

References (5)

1. Coodwin F, Jamison K. Manic-Depressive Illness. Oxford University Press: New York, 1990.
2. Schou M. Lithium Treatment of Manic Depressive Illness. A Practical Guide. Karger: Basel, 1989.
3. Maj M, Arena F, Lovero N, Pirozzi R, Kemali D. Factors associated with response to lithium prophylaxis in DSM III major depression and bipolar disorder. Pharmacopsychiatry 1985; 18: 309-313.
4. Maj M, Pirozzi R, Starace F. Previous pattern of course of the illness as a predictor of response to lithium prophylaxis in bipolar patients. I Affect Disord 1989; 17: 237-241.
5. OConnell RA, Mayo JA, Flatow L, Cuthbertson BO, Brien BE. Outcome of bipolar disorder on long-term treatment with lithium. Br J Psychiatry 1991; 159: 123-129.